NMTC logo

NMTC

Profile

Full Name

NeuroOne Medical Technologies Corporation

Ticker Symbol

NMTC

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 15, 2018

Indexes

Not included

Website

http://nmtc1.com

Employees

17

Key Details

Price

$0.47(+9.30%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.45M(+76.86% YoY)

Annual EPS

-$0.46(+29.23% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.47
NMTC price is $0.47

30-Day Relative Volume

0.87
NMTC 30-day relative volume is 0.87

Price Performance

Price Most recent change

+9.3%
NMTC price was up +9.3% on Apr 11, 2025

Price YTD change

-43.1%
NMTC price is down -43.1% since January 1st

Price 1-year change

-61.16%
NMTC price is down -61.16% year-on-year

Price 3-year change

-55.02%
NMTC price is down -55.02% over the past 3 years

Price Range

Price All-time high

$30.00
NMTC price is currently -98.43% below its historical high of $30.00

Price 3-year low

$0.40
NMTC price is currently +18.99% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$14.51M
NMTC market capitalization is $14.51 million

Market cap 3-year change

-14.27%
NMTC market capitalization is down -14.27% over the past 3 years

Market cap All-time high

$129.94M
NMTC market capitalization is currently -88.84% below its historical high of $129.94 million

Market cap sector rank

24.98%
NMTC market capitalization is higher than 24.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.25%
NMTC shares outstanding is up +17.25% year-on-year

Shares Outstanding 3-Year Change

+90.61%
NMTC shares outstanding is up +90.61% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.92
NMTC beta is 0.92

200-day SMA

$0.89
NMTC price is currently -47.03% below its 200-day simple moving average

50-day SMA

$0.96
NMTC price is currently -51.12% below its 50-day simple moving average

RSI

23.32
NMTC 14-day relative strength index is 23.32

Volume

0.87
NMTC 30-day relative volume is 0.87

ATR

$0.09
NMTC average true range is $0.09

10-day Historical Volatility

235.65%
NMTC 10-day historical volatility is 235.65%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.45M
NMTC annual revenue is $3.45 million

Revenue Analysts estimate

$13.30M
NMTC annual revenue is currently -74.04% lower than the consensus analysts' forecast

Revenue 1-year change

+76.86%
NMTC annual revenue is up +76.86% year-on-year

Revenue Sector rank

19.37%
NMTC annual revenue is higher than 19.37% of companies in Healthcare sector

EPS

EPS

-$0.46
NMTC annual earnings per share is -$0.46

EPS Analysts estimate

-
NMTC annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+29.23%
NMTC annual earnings per share is up +29.23% year-on-year

EPS Sector rank

70.36%
NMTC annual earnings per share is higher than 70.36% of companies in Healthcare sector

Profit

Gross profit

$1.08M
NMTC annual gross profit is $1.08 million

Gross margin

31.27%
NMTC annual gross profit margin is 31.27%

Operating profit

-$11.89M
NMTC annual operating income is -$11.89 million

Operating margin

-344.26%
NMTC annual operating profit margin is -344.26%

Net income

-$12.32M
NMTC annual net profit is -$12.32 million

Net margin

-356.74%
NMTC annual net profit margin is -356.74%

Expenses

Total expenses

$15.34M
NMTC annual total expenses is $15.34 million

Operating expenses

$12.97M
NMTC annual total operating expenses is $12.97 million

Cost of goods sold

$2.37M
NMTC annual cost of goods sold is $2.37 million

Selling, general & administrative expenses

$7.90M
NMTC annual SGA is $7.90 million

Depreciation and amortization

$246.80K
NMTC annual depreciation & amortization is $246.80 thousand

Interest expense

$229.00K
NMTC annual interest expense is $229.00 thousand

Income tax

$0.00
NMTC annual income tax is $0.00

EBIT & EBITDA

EBIT

-$12.09M
NMTC annual earnings before interest & taxes is -$12.09 million

EBITDA

-$11.84M
NMTC annual EBITDA is -$11.84 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.37M
NMTC annual total assets is $5.37 million

Non current assets

$739.00K
NMTC annual long term assets is $739.00 thousand

Current assets

$4.63M
NMTC annual total current assets is $4.63 million

Cash and cash equivalents

$1.46M
NMTC annual cash & cash equivalents is $1.46 million

Accounts receivable

$176.60K
NMTC annual accounts receivable is $176.60 thousand

Inventory

$2.64M
NMTC annual inventory is $2.64 million

Liabilities

Total liabilities

$4.55M
NMTC annual total liabilities is $4.55 million

Long term liabilities

$2.33M
NMTC annual total long term liabilities is $2.33 million

Current liabilities

$2.21M
NMTC annual total current liabilities is $2.21 million

Accounts payable

$1.03M
NMTC annual accounts payable is $1.03 million

Debt

Total debt

$260.20K
NMTC annual total debt is $260.20 thousand

Total debt 1-year change

+41.11%
NMTC annual total debt is up +41.11% year-on-year

Long term debt

$194.40K
NMTC annual long term debt is $194.40 thousand

Short term debt

$65.80K
NMTC annual short term debt is $65.80 thousand

Equity & Capital

Shareholders equity

$822.00K
NMTC annual stockholders equity is $822.00 thousand

Book value

$822.00K
NMTC annual book value is $822.00 thousand

Retained earnings

-$75.00M
NMTC annual retained earnings is -$75.00 million

Working capital

$2.42M
NMTC annual working capital is $2.42 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.01M
NMTC annual cash flow from operations is -$11.01 million

Cash from operations 1-year change

+14.55%
NMTC annual cash flow from operations is up +14.55% year-on-year

Cash from investing

-$120.20K
NMTC annual cash flow from investing activities is -$120.20 thousand

Cash from investing 1-year change

-104.54%
NMTC annual cash flow from investing activities is down -104.54% year-on-year

Cash from financing

$7.27M
NMTC annual cash flow from financing activities is $7.27 million

Cash from financing 1-year change

-1.75%
NMTC annual cash flow from financing activities is down -1.75% year-on-year

CAPEX

CAPEX

$120.20K
NMTC annual capital expenditures is $120.20 thousand

CAPEX 1-year change

-68.71%
NMTC annual capital expenditures is down -68.71% year-on-year

Free Cash Flow

Free cash flow

-$11.13M
NMTC annual free cash flow is -$11.13 million

Free cash flow 1-year change

+16.12%
NMTC annual free cash flow is up +16.12% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

31.27%
NMTC annual gross profit margin is 31.27%

Operating margin

-344.26%
NMTC annual operating profit margin is -344.26%

Net margin

-356.74%
NMTC annual net profit margin is -356.74%

ROA & ROE

ROA

-182.93%
NMTC annual return on assets is -182.93%

ROE

-348.39%
NMTC annual return on equity is -348.39%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NMTC price to earnings ratio value is unknown

PE ratio Sector rank

-
NMTC price to earnings ratio is unknown

PB Ratio

PB ratio

4.94
NMTC price to book ratio is 4.94

PB ratio Sector rank

83.14%
NMTC price to book ratio is higher than 83.14% of companies in Healthcare sector

PS Ratio

PS ratio

2.52
NMTC price to sales ratio is 2.52

PS ratio Sector rank

47.69%
NMTC price to sales ratio is higher than 47.69% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.71M
NMTC enterprise value is $13.71 million

Enterprise value Sector rank

28.69%
NMTC enterprise value is higher than 28.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.16
NMTC EV/EBITDA is -2.16

EV/EBITDA Sector rank

29.77%
NMTC EV/EBITDA is higher than 29.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.09
NMTC annual current ratio is 2.09

Quick ratio

0.90
NMTC annual quick ratio is 0.90

Leverage

Debt to equity

0.00
NMTC annual debt to equity ratio is 0.00

Interest coverage ratio

-52.79
NMTC annual interest coverage ratio is -52.79

Risk & Stability

Piotroski F-Score

3
NMTC piotroski f-score is 3

Altman Z-Score

-23.89
NMTC altman z-score is -23.89

Analyst ratings

Recent major analysts updates

Aug 15, 23 Alliance Global Partners
Buy
Mar 28, 22 Craig-Hallum
Hold
Dec 3, 21 Alliance Global Partners
Buy
Nov 15, 21 Craig-Hallum
Buy

Institutional Ownership

Similar stocks

ALUR logo
Allurion Technologies (ALUR)
BIVI logo
BioVie (BIVI)
MIRA logo
MIRA Pharmaceuticals (MIRA)
PRTG logo
Portage Biotech (PRTG)
AXDX logo
Accelerate Diagnostics (AXDX)
CLDI logo
Calidi Biotherapeutics (CLDI)
CING logo
Cingulate (CING)
LFWD logo
ReWalk Robotics (LFWD)
Abpro (ABP)
  • What is the ticker symbol for NeuroOne Medical Technologies?
  • Does NeuroOne Medical Technologies pay dividends?
  • What sector is NeuroOne Medical Technologies in?
  • What industry is NeuroOne Medical Technologies in?
  • What country is NeuroOne Medical Technologies based in?
  • When did NeuroOne Medical Technologies go public?
  • Is NeuroOne Medical Technologies in the S&P 500?
  • Is NeuroOne Medical Technologies in the NASDAQ 100?
  • Is NeuroOne Medical Technologies in the Dow Jones?
  • When was NeuroOne Medical Technologies's last earnings report?
  • When does NeuroOne Medical Technologies report earnings?
  • Should I buy NeuroOne Medical Technologies stock now?

What is the ticker symbol for NeuroOne Medical Technologies?

The ticker symbol for NeuroOne Medical Technologies is NASDAQ:NMTC

Does NeuroOne Medical Technologies pay dividends?

No, NeuroOne Medical Technologies does not pay dividends

What sector is NeuroOne Medical Technologies in?

NeuroOne Medical Technologies is in the Healthcare sector

What industry is NeuroOne Medical Technologies in?

NeuroOne Medical Technologies is in the Medical Devices industry

What country is NeuroOne Medical Technologies based in?

NeuroOne Medical Technologies is headquartered in United States

When did NeuroOne Medical Technologies go public?

NeuroOne Medical Technologies's initial public offering (IPO) was on March 15, 2018

Is NeuroOne Medical Technologies in the S&P 500?

No, NeuroOne Medical Technologies is not included in the S&P 500 index

Is NeuroOne Medical Technologies in the NASDAQ 100?

No, NeuroOne Medical Technologies is not included in the NASDAQ 100 index

Is NeuroOne Medical Technologies in the Dow Jones?

No, NeuroOne Medical Technologies is not included in the Dow Jones index

When was NeuroOne Medical Technologies's last earnings report?

NeuroOne Medical Technologies's most recent earnings report was on Feb 12, 2025

When does NeuroOne Medical Technologies report earnings?

The next expected earnings date for NeuroOne Medical Technologies is May 14, 2025

Should I buy NeuroOne Medical Technologies stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page